The Valley Desk

NCT06616584 · Interventional trial

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Overall registry status Recruiting

Phase 2 · Phase 3

Conditions Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov